National Bank Of Canada Cti Biopharma Corp Transaction History

National Bank Of Canada

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$3.55 - $6.27 $17,750 - $31,349	-5,000 Reduced 99.9%	5 $0
Q1 2022 May 05, 2022	BUY	$1.9 - $5.23 $9,500 - $26,150	5,000 Added 100000.0%	5,005 $23,000
Q4 2021 Jan 24, 2022	BUY	$1.44 - $2.86 $7 - $14	5 New	5 $0

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.